🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Brian Slomovitz, MD, MS, FACOG Amazing conversation between patient advocate Tiffany and Brian Slomovitz, MD, MS, FACOG on supporting all people. "I'm going to throw the numbers out there, which are disturbing to hear, but which are facts. Black women have a twice as two times chance of dying from endometrial cancer than

To read the full publication, click link in bio or go to ow.ly/5Cqz50SrWZQ. #clinicaltrials #GOGF #GOGPartners #GynecologicOncology #cervicalcancer Krish Tewari, MD @drleslie214 @Bpothuri Brian Slomovitz, MD, MS, FACOG

📢@ESMO24 concomitant paper: Important data from the ENGOT-en11/GOG-3053/KEYNOTE-B21trial - adjuvant pembrolizumab plus in high-risk endometrial cancer. #ESMO24 #EndometrialCancer #pembrolizumab Brian Slomovitz, MD, MS, FACOG tinyurl.com/2alumknm

WE'RE LIVE TOMORROW! 🚺 Endometrial cancer care is evolving! Is your clinical knowledge? Don't miss this review of the latest guidelines + strategies for adjuvant therapy w/ leading experts, including Brian Slomovitz, MD, MS, FACOG David OMalley! Click to Join 👉 ms.spr.ly/6014mp2S4

Join us 9/28 for Oncology Congress & earn free CME/CE! Get updates on breast cancer, endometrial cancer, melanoma, bladder cancer & NSCLC. Speakers include Brian Slomovitz, MD, MS, FACOG, Dr. Rebecca Heist, Harold J. Burstein, MD, PhD, FASCO, Daniel Petrylak, David M. Miller MD, PhD, FAAD & Sucharu Prakash, MD. ow.ly/hGKM50TuE7O

Looking forward to participating in this great CME event. I am honored to be on a lineup of speakers with these leaders.

I am honored to be a part of this session with 2 colleagues from THE Ohio State. David OMalley The GOG Foundation Inc. Mount Sinai Miami OB/GYN Mount Sinai Medical Center IGCS IJGC IJGC Fellows

New KEYNOTE-B21 #ClinicalTrial data in Journal of Clinical Oncology was presented today at the #IGCS2024: pembrolizumab + chemotherapy may improve disease-free survival for high-risk #EndometrialCancer patients with dMMR tumors. Read more: brnw.ch/21wNPc1 #oncology Brian Slomovitz, MD, MS, FACOG #gyncsm

So excited for this!

Honored to participate in a recent IJGC conversations with one of my great mentors Pedro T Ramirez

Honored to discuss our practice changing study using tisotumab vedotin in patients recurrent cervical cancer. Led to full FDA approval. Really cool to discuss with my good friend, colleague, and leader of the cervical cancer portfolio The GOG Foundation Inc. @drleslie214 Mount Sinai Medical Center

Congrats!!! Phenomenal work. You should be proud!!

So much fun seeing the presentations by the gyn onc fellows. Really great work. The GOG Foundation Inc.

Exciting breakthrough for our patients with ovarian cancer. The GOG Foundation Inc. Mount Sinai Medical Center Corcept Therapeutics IGCS foxnews.com/health/experim…

facebook.com/share/v/16Jhpp… So honored to take care of courageous women like Jackie. It is a privilege for me to have the opportunity to take care of my patients. Mount Sinai Medical Center

#Editorial The challenge is no longer whether precision oncology can improve outcomes in #endometrialcancer but how rapidly and effectively these advancements can be integrated into standard clinical practice. 📌 bit.ly/4363lDa Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj

Honored to work with such an esteemed group of global leaders. Angelica Nogueira Rodrigues Glauco Baiocchi Mario M. Leitao, Jr Mount Sinai Medical Center

pubmed.ncbi.nlm.nih.gov/40253116/ Does metformin work to cure #endometrialcancer? Vivek Podder, MBBS Mount Sinai Medical Center NRG Oncology The GOG Foundation Inc. Mount Sinai Medical Center

pubmed.ncbi.nlm.nih.gov/40233470/ Using precision molecular classifications to treat endometrial cancer! So many new options for our patients. Vivek Podder, MBBS Mount Sinai Medical Center

Honored to be a co-investigator on this practice changing trial. The GOG Foundation Inc. Mount Sinai Medical Center